David R Liljenquist
Overview
Explore the profile of David R Liljenquist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
583
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bailey T, Liljenquist D, Denham D, Brazg R, Ioacara S, Masciotti J, et al.
Diabetes Technol Ther
. 2025 Jan;
PMID: 39869118
The implanted Eversense Continuous Glucose Monitoring (CGM) System transitioned from 90- to 180- to 365-day durations marketed today. This report summarizes the 365-day clinical study. ENHANCE was a prospective, multicenter...
2.
Carlson A, Graham T, Akturk H, Liljenquist D, Bergenstal R, Sulik B, et al.
J Diabetes Sci Technol
. 2024 Mar;
18(6):1288-1292.
PMID: 38439656
Background: Control-IQ technology version 1.5 allows for a wider range of weight and total daily insulin (TDI) entry, in addition to other changes to enhance performance for users with high...
3.
Lord S, Bahnson H, Greenbaum C, Liljenquist D, Virostko J, Speake C
PLoS One
. 2023 Dec;
18(12):e0293268.
PMID: 38096190
Studies of new therapies to preserve insulin secretion in early type 1 diabetes require several years to recruit eligible subjects and to see a treatment effect; thus, there is interest...
4.
Pihoker C, Shulman D, Forlenza G, Kaiserman K, Sherr J, Thrasher J, et al.
Diabetes Technol Ther
. 2023 Oct;
25(11):755-764.
PMID: 37782145
During MiniMed™ advanced hybrid closed-loop (AHCL) use by adolescents and adults in the pivotal trial, glycated hemoglobin (A1C) was significantly reduced, time spent in range (TIR) was significantly increased, and...
5.
Alva S, Brazg R, Castorino K, Kipnes M, Liljenquist D, Liu H
Diabetes Ther
. 2023 Mar;
14(4):767-776.
PMID: 36877403
Introduction: We have evaluated the performance of the FreeStyle Libre® 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged ≥ 6 years and...
6.
Garg S, Grunberger G, Weinstock R, Lawson M, Hirsch I, DiMeglio L, et al.
Diabetes Technol Ther
. 2022 Dec;
25(1):1-12.
PMID: 36472543
To evaluate safety and effectiveness of MiniMed™ 670G hybrid closed loop (HCL) in comparison with continuous subcutaneous insulin infusion (CSII) therapy for 6 months in persons with type 1 diabetes...
7.
Forlenza G, Ekhlaspour L, DiMeglio L, Fox L, Rodriguez H, Shulman D, et al.
Pediatr Diabetes
. 2022 Jan;
23(3):324-329.
PMID: 35001477
Background: Highly variable insulin sensitivity, susceptibility to hypoglycemia and inability to effectively communicate hypoglycemic symptoms pose significant challenges for young children with type 1 diabetes (T1D). Herein, outcomes during clinical...
8.
Alva S, Bailey T, Brazg R, Budiman E, Castorino K, Christiansen M, et al.
J Diabetes Sci Technol
. 2020 Sep;
16(1):70-77.
PMID: 32954812
Background: In this study, we evaluated the analytical performance of the second-generation factory-calibrated FreeStyle Libre Flash Glucose Monitoring (FreeStyle Libre 2) System compared to plasma venous blood glucose reference, Yellow...
9.
Forlenza G, Pinhas-Hamiel O, Liljenquist D, Shulman D, Bailey T, Bode B, et al.
Diabetes Technol Ther
. 2018 Dec;
21(1):11-19.
PMID: 30585770
Objective: To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Methods: Participants (N = 105, ages 7-13...
10.
Wood M, Shulman D, Forlenza G, Bode B, Pinhas-Hamiel O, Buckingham B, et al.
Diabetes Technol Ther
. 2018 Oct;
20(11):731-737.
PMID: 30299976
Background: The Medtronic predictive low-glucose management (PLGM) algorithm automatically stops insulin delivery when sensor glucose (SG) is predicted to reach or fall below a preset low-glucose value within the next...